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Abstract We have attempted to elucidate the precise mechan-
ism of nitric oxide (NO)-induced apoptotic neuronal cell death.
Enzymatic cleavages of DEVD-AFC, VDVAD-AFC, and
LEHD-AFC (specific substrates for caspase-3-like protease
(caspase-3 and -7), caspase-2, and caspase-9, respectively) were
observed by treatment with NO. Western blot analysis showed
that pro-forms of caspase-2, -3, -6, and -7 are decreased during
apoptosis. Interestingly, Ac-DEVD-CHO, a caspase-3-like
protease inhibitor, blocked not only the decreases in caspase-2
and -7, but also the formation of p17 from p20 in caspase-3
induced by NO, suggesting that caspase-3 exists upstream of
caspase-2 and -7. Bongkrekic acid, a potent inhibitor of
mitochondrial permeability transition, specifically blocked both
the loss of mitochondrial membrane potential and subsequent
DNA fragmentation in response to NO. Thus, NO results in
neuronal apoptosis through the sequential loss of mitochondrial
membrane potential, caspase activation, and degradation
of inhibitor of caspase-activated DNase (CAD) (CAD
activation). ß 2000 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Caspases comprise a structurally related group of cysteine
proteases that share a dominant primary speci¢city for cleav-
ing peptide bonds following Asp residues. To date, 14 mam-
malian homologues of caspases have been identi¢ed and clas-
si¢ed into three groups based on their homology, structure,
and substrate speci¢city [1,2]. Caspases are typically constitu-
tively present within cells as inactive zymogens that require
proteolytic processing to achieve their active, two-chain con-
¢gurations [3^6]. Caspases are known to cleave a number of
proteins, including other caspases. In consequence, it is be-
lieved that apoptosis occurs in a caspase-sensitive manner.
A direct activation of caspase-mediated apoptosis has been
found to involve cytochrome c, an essential component of the
mitochondrial respiratory chain [7]. In many systems, the re-
lease of cytochrome c from mitochondria to the cytosol has
been demonstrated to be a crucial step in the activation of
apoptosis [8^10]. Once released from mitochondria, cyto-
chrome c, in interaction with apoptotic protease activity
factor-1 (Apaf-1) and caspase-9, initiates the cleavage and
activation of caspase-3 [11]. Active caspase-3 in turn activates
other executive caspases and leads to the subsequent charac-
teristic features of apoptosis, including the cleavage of fodrin
and lamin, chromatin condensation, and nuclear fragmen-
tation [12]. In particular, it has recently been reported that
inhibitor of caspase-activated DNase (ICAD) and acinus, im-
portant factors in DNA fragmentation and condensation,
have been isolated and identi¢ed to be substrates for cas-
pase-3 [13^15]. On the other hand, Bcl-2 and other related
anti-apoptotic proteins can prevent cytochrome c release
and inhibit caspase activation and apoptosis [8,9,16].
Although the mechanisms by which cytochrome c is released
from the mitochondria remain unknown, some observations
suggest that cytochrome c-mediated apoptosis is probably dis-
tinct from that mediated by AIF [17].
It is widely accepted that inducible nitric oxide (NO) syn-
thase, which produces a large amount of NO, is expressed in
response to several stresses, including brain ischemia and
treatment with bacterial endotoxin and in£ammatory cyto-
kines [18^20]. Although NO is involved in neurotoxicity after
several stresses such as ischemia, the crucial mechanism of
NO-induced cytotoxicity is still unclear. Some mechanisms
regarding NO-induced cytotoxicity in neurons have been
proposed. It has been reported that NO can enhance ADP-
ribosylation or S-nitrosylation of an increasing number of
proteins, and two of these proteins have been identi¢ed as
NO-target proteins [21,22]. One is glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), which is S-nitrosylated by NO,
thereby inhibiting enzyme activity. GAPDH is known to be a
key enzyme in the glycolytic conversion of glucose to pyruvic
acid and represents an important pathway for carbohydrate
metabolism in most organisms [23]. Hence, the inhibition of
GAPDH activity by NO would diminish the amount of ATP
formed from glycolysis and decrease the £ow of substrates to
the electron transport chain. NO also activates poly ADP-
ribosyl synthetase (PARS) in association with damage to
DNA [22]. The damage may be a critical event in NO neuro-
toxicity through the N-methyl-D-aspartate receptor. DNA
damage stimulates PARS activity, resulting in the addition
of a large number of ADP-ribose groups to substrates such
as histones and PARS itself. Once massive DNA damage and
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the associated extensive activation of PARS occur, L-nicotin-
amide adenine dinucleotide, which is the donor of the ADP-
ribose groups, is depleted. Consequently, it is believed that
ATP is also depleted, with cell death occurring due to energy
depletion. In addition to the indicated above actions of NO, a
small GTP-binding protein Ras, mitogen-activated protein ki-
nase (MAPK), stress-activated protein kinase, and p38
MAPK have been found to be activated by NO in several
cells [24^28]. These ¢ndings indicate that NO can modulate
the intracellular signal transduction activated by growth fac-
tors, cytokines, or stresses.
We have recently demonstrated that NO triggers apoptotic
neuronal death via caspase activation following mitochondrial
damage [29]. Moreover, NO elicits the release of cytochrome c
into the cytosol during apoptosis. These results suggest that
both the stimulation of caspase activity and cytochrome c
release are heavily involved in NO-induced neuronal apopto-
sis. However, a detailed mechanism for the NO activation of
the death signal has not yet been determined. In the current
study, we attempted to elucidate the mechanism of NO-in-
duced neuronal apoptosis.
2. Materials and methods
2.1. Materials
Synthetic peptide-based substrates for caspase-3-like protease (N-
acetyl-Asp-Glu-Val-Asp-7-amino-4-tri£uoromethylcoumarin (Ac-
DEVD-AFC)), caspase-2 (N-acetyl-Val-Asp^Val-Ala-Asp-7-amino-4-
tri£uoromethylcoumarin (Ac-VDVAD-AFC)), and caspase-9 (N-ace-
tyl-Leu-Glu-His-Asp-7-amino-4-tri£uoromethylcoumarin (Ac-LEHD-
AFC)) were purchased from MBL (Nagoya, Japan). NOC18 was
from Dojindo Laboratory (Kumamoto, Japan). Anti-caspase-2, -3,
-6, -7 antibodies were purchased from Pharmingen (USA). Cyclospor-
in A (CsA) and bongkrekic acid (BA) were from Sigma (USA) and
BIOMOL (USA), respectively.
2.2. Cell culture
Human SH-SY5Y cells were maintained in Dulbecco’s modi¢ed
Eagle medium supplemented with 10% (v/v) heat-inactivated fetal
calf serum, 50 Wg/ml penicillin, and 100 Wg/ml streptomycin at 37‡C
in humidi¢ed 5% CO2/95% air.
2.3. Assay for caspase activity
Caspase-2, -3, -7, and -9 activities were measured using caspase-2,
caspase-3, and caspase-9 £uorometric protease assay kits. This assay
is based on detecting the cleavage of substrate VDVAD-AFC (cas-
pase-2), DEVD-AFC (caspase-3 and -7), or LEHD-AFC (caspase-9),
as described previously [30,31]. Brie£y, cells were treated with 250 WM
NOC18 for the indicated periods. At the appropriate time, the me-
dium was aspirated, and the cells were washed with phosphate-bu¡-
ered saline and added to 50 Wl of ice-cold cell lysis bu¡er. The cells
were incubated for 10 min on ice and then the cell lysates were cen-
trifuged for 30 min at 15 000 rpm at 4‡C. Next, cleared lysate (100 Wg
of protein) was incubated at 37‡C for 1 h with adding to 50 Wl of
reaction bu¡er containing 50 WM substrate. The amounts of released
AFC were measured with a £uorescent spectrophotometer with exci-
tation at 400 nm and emission at 505 nm.
Fig. 1. NO activates caspases. A: Time-course of the activation of substrate cleaving activity in cell extracts after NOC18 challenge. The cells
were stimulated with 250 WM NOC18 for the indicated periods (0^48 h). Cell lysates were then prepared, and an aliquot (100 Wg) was used for
caspase-2, -3-like proteases, and caspase-9 assay. A comparison of the £uorescence of AFC with that of an unstimulated sample allows for the
determination of the fold increase in caspase activity. Data are the means of triplicate runs in parallel. B: Decrease in pro-forms of caspase-2,
-3, -6, and -7 in response to NOC18 in SH-SY5Y cells. The cells were incubated with 250 WM NOC18 for various periods. Total cell lysates
were prepared and then subjected to Western blot analysis using speci¢c antibodies for caspase-2 (C-20, Santa Cruz), caspase-3, -6, and -7
(Pharmingen). Kinetic analyses of the levels of caspases are shown. Each cleaved fragment during apoptosis is indicated by an arrow. C: West-
ern blot analysis of the cleavage of ICAD amino-terminal region by caspase(s) during NOC18-mediated apoptosis in SH-SY5Y cells. The same
cell lysates shown in B were examined by Western blotting with an ICAD amino-terminal-speci¢c. The p17 fragment, DFF-45 (NT), generated
is indicated, as well as the DFF-45 and DFF-45-partial (in this case referring to the alternatively spliced, partial length DFF-45 protein) prod-
ucts. Only the DFF-45 amino-terminal-speci¢c antiserum detects the second, smaller DFF-45 alternatively spliced product.
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2.4. Western blot analysis
The cells were collected and suspended in 50 mM Tris^HCl (pH
7.4), 137 mM NaCl, 2 mM EDTA, 1 mM phenylmethylsulfonyl £uo-
ride, 10 Wg/ml aprotinin, and 10 Wg/ml leupeptin. The cells were then
disrupted by a Dounce homogenizer with 20 strokes and centrifuged
at 15 000 rpm for 20 min at 4‡C, as described [32,33]. The superna-
tants were used for the immunoblotting of caspase-2, -3, -6, and -7,
cytochrome c, and ICAD, as described previously [30,34]. 20 Wg of
protein was separated on sodium dodecyl sulfate (SDS)^polyacryl-
amide gels and transferred onto a nitrocellulose membrane. The fol-
lowing were used as primary antibodies: anti-human caspase-2, -3, -6,
and -7, cytochrome c (Pharmingen), and anti-human DFF-40 (ICAD)
(MBL, Japan). Horseradish peroxidase-conjugated anti-mouse or rab-
bit IgG (Amersham) was used as the secondary antibody. Detection
of the bands was performed using the ECL system (Amersham).
2.5. Detection of mitochondrial membrane potential
Mitochondrial membrane potential was measured by the incorpo-
ration of the cationic £uorescent dye rhodamine 123. Brie£y, cells
were incubated for 15 min at 37‡C in the presence of 10 WM rhod-
amine 123. Fluorescent intensity was analyzed with a FACScan Flow
Cytometer (Becton Dickinson). As a control experiment, cells were
incubated with 50 WM carbonyl cyanide m-chlorophenylhydrazone
(mCICCP), an uncoupler.
2.6. Detection of reactive oxygen species (ROS) generation
To measure the ROS generation in response to NOC, cells were
exposed to 5 WM 2P,7P-dichloro£uorescein diacetate (DCFH-DA) for
10 min at 37‡C. The £uorescent intensity was analyzed with a FACS-
can Flow Cytometer (Becton Dickinson).
2.7. Assessment of apoptosis by deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling (TUNEL)
The apoptotic cells were detected by TUNEL of nucleosomal frag-
ments generated by endonuclease cleavage using a MEBSTAIN Ap-
optosis kit II (MBL), as reported previously [35]. All images were
taken on a laser-scanning confocal microscope (LSM510; Carl Zeiss).
3. Results
3.1. NO-induced caspase activation in SH-SY5Y cells
We initially investigated the e¡ect of NOC18, an NO do-
nor, on caspase activation. Detergent extracts prepared from
the cells at various periods after a 250 WM NOC18 treatment
were tested for the cleaving activity of three £uorogenic pep-
tide substrates (DEVD-AFC, VDVAD-AFC, and LEHD-
AFC). DEVD-AFC is a £uorogenic, tetrapeptide substrate
that is cleaved by caspase-3-like protease (mainly caspase-3
and -7). VDVAD-AFC and LEHD-AFC are speci¢c sub-
strates for caspase-2 and caspase-9, respectively. All enzymatic
cleavages of DEVD-AFC, VDVAD-AFC, and LEHD-AFC
were detected 12 h after the NOC18 challenge. Their cleaving
activities were clearly elevated and sustained with NOC18
treatment. Maximal DEVD-AFC, VDVAD-AFC, and
LEHD-AFC cleaving activities were detected at 24 h follow-
ing NOC18 treatment (Fig. 1A). We next evaluated the cleav-
age of each caspase in response to NOC18 by Western blot
analysis. Caspase-2, -3, -6, and -7 are synthesized as precursor
molecules, and are approximately 48, 32, 34, and 34 kDa in
size, respectively. Immunoblotting analysis revealed that pro-
forms of each caspase decrease in NOC18-treated cells in a
time-dependent manner (Fig. 1B). In particular, new bands
corresponding to p20 and p17 of caspase-3 were detected at
18 h after NOC18 challenge in samples in which the process-
ing of pro-caspase-3 was evident. The p11 active subunit of
caspase-6 was detected at 36 h after treatment with NOC18.
Moreover, the intermediate band p32 of caspase-7 (lack of
prodomain) was visible after a 12 h incubation period with
250 WM NOC18 with the use of anti-caspase-7 antibody, a
Fig. 2. Sensitivity of caspase-2, -3, and -7 activation to an irreversible inhibitor of caspase-3-like protease (Ac-DEVD-CHO) in NOC18-treated
SH-SY5Y cells. SH-SY5Y cells were treated or not treated with several concentrations of Ac-DEVD-CHO, a cell-permeable caspase-3-like pro-
tease inhibitor, for 30 min before NOC18 challenge. The cells were then incubated with 250 WM NOC18 for various periods (0^36 h) and sub-
jected to Western blot analysis. E¡ects of Ac-DEVD-CHO on the processing of caspase-2 and -7 (A), and caspase-3 (B) are shown. In B, aster-
isk shows the cleavage product 22 kDa in size, which reacts with anti-caspase-3 antibody.
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peptide corresponding to amino acids 25^42 of human cas-
pase-7, as an immunogen (Fig. 1B). Further, immunoblotting
analysis using anti-cleaved caspase-7 (20 kDa) antibody de-
tected the presence of p20 in caspase-7 36 h after that treat-
ment. We next examined whether or not NOC18 cleaves the
ICAD, a substrate for caspase-3 and -7, using these same cell
lysates by Western blotting with an ICAD amino-terminal-
speci¢c antibody. In the quiescent state, ICAD 45 and 38
kDa in size were found to exist in SH-SY5Y cells (Fig. 1C).
Each full-length ICAD (45 and 38 kDa) was decreased in
response to NOC18 in a time-dependent manner. A new
band corresponding to a breakdown product of ICAD 17
kDa in size was detected 24 h after NOC18 challenge in sam-
ples in which the cleaving of ICAD was evident.
3.2. E¡ects of Ac-DEVD-CHO on caspase processing by
NOC18
We investigated the e¡ects of Ac-DEVD-CHO, a caspase-3-
like protease inhibitor, on caspases processing in response to
NOC18. Treatment with Ac-DEVD-CHO was found to sup-
press the processing of pro-forms of caspase-2 and -7 in a
concentration-dependent manner (Fig. 2A). Interestingly, the
cleavage of pro-caspase-3 to a p20 fragment was insensitive to
Ac-DEVD-CHO; the processing of p20 to p17, however, was
inhibited by the treatment with Ac-DEVD-CHO (Fig. 2B).
3.3. ROS generation and the mitochondrial permeability
transition by NOC18
The generation of ROS was detected by FACScan analysis
using DCFH-DA. NOC18 treatment for 1 h caused a pro-
gressive increase in the production of ROS in SH-SY5Y cells
(Fig. 3A). Kinetic analysis showed that ROS generation in
response to NOC18 is signi¢cantly elevated 8 h after treat-
ment, with these levels continuing for up to 24 h. Variations in
the cellular content of the cationic lipophilic £uorescent dye
rhodamine 123 were determined by FACScan analysis to eval-
uate the changes in mitochondrial membrane potential.
Twelve hours after NOC18 challenge, the cells in which the
£uorescent intensity of rhodamine 123 had decreased were
detected (Fig. 3B). Exposure of SH-SY5Y cells to NOC18
produced decreases in the percentage of cells with high rhod-
amine 123 staining, representing a fall in the mitochondrial
membrane potential in a time-dependent manner (Fig. 3B).
3.4. E¡ects of permeability transition inhibitors on
NOC18-induced loss of mitochondrial function
CsA and BA are known to inhibit cyclophilin D and ad-
enine nucleotides translocator in the mitochondrial permeabil-
ity transition pore complex (PTPC), respectively. Both BA
and CsA, but not FK506 (data not shown), signi¢cantly re-
covered from the loss of mitochondrial membrane potential in
response to NOC18 (Fig. 4A). In this case, treatment with
CsA was capable of attenuating the release of cytochrome c
into the cytosol fraction in response to NOC18 (Fig. 4B). We
evaluated the e¡ects of BA on NOC18-induced neuronal ap-
optosis. Exposure of SH-SY5Y cells to NOC18 for 24 h re-
sulted in apoptotic cell death, as estimated by TUNEL stain-
ing. In contrast, the numbers of DNA-fragmented (TUNEL-
positive) cells were remarkably reduced in the BA-pretreated
cells (Fig. 4C).
Fig. 3. ROS production and the reduction of mitochondrial mem-
brane potential after NOC18 treatment in neuronal cells. A: Kinetic
analysis of ROS production by NOC18 treatment. Cells were incu-
bated with 250 WM NOC18 for various periods (0^24 h) and then
stained for 10 min with 5 WM DCFH-DA before assay. Thereafter,
the cells were washed twice, placed into suspension, and evaluated
on the £ow cytometer (£uorescence-activated cell sorting). The per-
centages re£ect the production of peroxides (DCF £uorescence).
Data are typical results from three independent experiments. B:
Changes in the mitochondrial membrane potential during NOC18-
induced apoptosis. Cells were incubated for 15 min at 37‡C with
the potential-sensitive dye rhodamine 123 (10 WM). After incuba-
tion, cells were immediately analyzed by a £ow cytometer. The re-
sults are representative of one of four separate experiments. The
percentage was quantitated using a FACScan Flow Cytometer. As a
control, cells were incubated before analysis with 50 WM mCICCP
for 1 h.
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4. Discussion
4.1. NO activates caspases
The purpose of the present study was to elucidate a detailed
mechanism for NO-induced apoptotic cell death in SH-SY5Y
neuroblastoma cells. We have reported previously that NO
induces apoptosis via cytochrome c release into the cytosol
and caspase activation in SH-SY5Y cells [29]. In the current
study, we assessed the mitochondrial function and character-
ized the caspase isoforms activated by NOC18 treatment. Ini-
tially, we investigated the cleavage activity of the peptide sub-
strate for each caspase. As shown in Fig. 1A, signi¢cant
caspase-2 (VDVAD-AFC cleaving activity), caspase-3 and -7
(DEVD-AFC cleaving activity), and caspase-9 (LEHD-AFC
cleaving activity) activities were detected in the extracted cy-
tosol fractions with the same time-courses. Enzymatic cleav-
ages of each £uorescent peptide substrate increased slightly
12 h after the addition of NOC18 and thereafter became ele-
vated for up to 36 h. These results suggest that caspases,
including at least caspase-2, -3, -7, and -9, are involved in
NOC18-induced apoptosis.
Western blot analysis revealed that the level of pro-caspase-
2 is decreased by NOC18 challenge in a time-dependent man-
ner, as reported previously. In addition, the active forms of
caspase-3 (p17 and p20), caspase-6 (p11), and caspase-7 (p20)
were also detected during apoptosis (Fig. 1B). These ¢ndings
suggest that NO activates several isoforms of caspases (at
least caspase-2, -3, -6, -7, and -9) in SH-SY5Y cells. In this
same study, we attempted the detection of caspase-9 by using
anti-caspase-9 antibody. Unfortunately, we could not detect
pro-caspase-9 even in the quiescent state, probably due to the
lower concentrations of this molecule (data not shown). In
agreement with this result, the cleaving activity of LEHD-
AFC was lower than those of DEVD-AFC and VDVAD-
AFC (Fig. 1A). Once apoptosis initiating factor (for example,
cytochrome c release into the cytosol) activates, even the low-
er levels of caspase-9 could be su⁄cient to activate the sequen-
tial caspases and following apoptosis. We have found that NO
cleaves several intracellular proteins such as PARP, lamin,
D4-GDI in a caspase-sensitive manner ([29], data not shown).
Under these conditions, NO results in apoptotic cell death
accompanying DNA fragmentation. We therefore attempted
to assess whether the activation of caspases in response to
NOC18 leads to the cleavage of ICAD by Western blot anal-
ysis with ICAD antibody. ICAD serves as both a speci¢c
inhibitor of CAD and as a molecular chaperone to ensure
proper folding of the endonuclease [13,14,36], and is a sub-
strate for caspase-3 and -7 that must be cleaved before apo-
ptotic internucleosomal DNA fragmentation can proceed
[7,13]. As shown in Fig. 1C, NOC18 promoted ICAD cleav-
age, as demonstrated by Western blot analysis, suggesting that
NO-induced apoptosis in SH-SY5Y cells occurs through the
cleavage and inactivation of ICAD by caspases.
To elucidate the cascade of caspase activation induced by
Fig. 4. E¡ects of permeability transition inhibitors on NOC18-induced changes in mitochondrial function. A: E¡ects of CsA and BA on the
loss of mitochondrial membrane potential by NOC18. Cells were pretreated with 1 WM CsA or 50 WM BA for 30 min prior to NOC18 chal-
lenge. The cells were then stimulated with 250 WM NOC18 for 24 h when exposed to similar concentrations of CsA or BA. The mitochondrial
membrane potential was analyzed as described in the legend for Fig. 3. B: Inhibitory e¡ects of CsA on NOC18-induced cytochrome c release
into the cytosol fraction. The cytosol fractions were separated by SDS^polyacrylamide gel electrophoresis and transferred onto a nitrocellulose
membrane. Cytochrome c was detected by Western blot analysis using a monoclonal antibody (7H8.2C12). C: Protective e¡ects of BA on
NOC18-induced DNA fragmentation. The apoptotic cells were detected by TUNEL of nucleosomal fragments generated by endonuclease cleav-
age. Scale bars: 50 Wm in left panels; 200 Wm in right panels.
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NOC18, we next examined the e¡ects of Ac-DEVD-CHO, a
caspase-3-like protease inhibitor, on the cleavages of caspase-
2, -3, and -7. Both the decrease in pro-caspase-2 and pro-
caspase-7 levels and the appearance of the cleaved product
of caspase-7 by challenge with NOC18 were recovered from
in response to the treatment with Ac-DEVD-CHO in a con-
centration-dependent manner. These results strongly indicated
that a DEVD-sensitive protease, possibly caspase-3, acts up-
stream of caspase-2 and -7. Interestingly, this inhibitor atte-
nuated only the NO-induced formation of the p17 product
from p20, but not p20 from pro-caspase-3 (p32). Thus, pro-
caspase-3 may be cleaved to a p20 form by other caspases
(possibly caspase-9) relatively insensitive to Ac-DEVD-CHO.
Subsequent cleavage from p20 to p17 is presumably autoca-
talytic, as it is completely inhibited by Ac-DEVD-CHO in a
concentration-dependent manner. Moreover, under these con-
ditions, a 22 kDa cleavage product was detected during
NOC18 challenge in the presence of Ac-DEVD-CHO (de-
noted by an asterisk in Fig. 2B). Similar results have been
reported from studies in which the 22^23 kDa fragment has
been observed after B cell antigen receptor ligation in B104
cells in the presence of low concentrations of Z-VDVAD-fmk
[37]. Although the characteristics of the cleavage product have
been investigated, it has been found to lack caspase-3 activity.
Taken together, these results indicate that the 22 kDa frag-
ment is generated via an Ac-DEVD-CHO-insensitive caspase.
Studies with the cleavage of £uorogenic peptide substrates,
Western blot analysis, and caspase inhibitors strongly suggest
that caspase-3 activation occurs upstream of caspase-2 and -7.
In particular, as it is well known that caspase-3 is activated by
caspase-9, our experiments suggest that (1) a DEVD-insensi-
tive caspase (possibly caspase-9) initially generates p20 and
p12, and then (2) DEVD-sensitive caspases (caspase-3 itself
and other caspases) generate p17 from p20 in the next step.
4.2. E¡ects of NO on mitochondrial function
In this report, we assessed the mitochondrial function and
role of NO-induced apoptosis. NO results in mitochondrial
damage and mitochondrial respiratory chain inhibition
[38,39]. In particular, NO binds reversibly to cytochrome c
oxidase (complex IV) in mitochondrial respiration [40]. There-
after, superoxide, which is also generated under these condi-
tions, can interact with NO to form peroxynitrite (ONOO3)
[41]. ONOO3 inhibits mitochondrial respiratory enzymes in
an irreversible manner, suggesting that ONOO3 may play a
major role in the inhibition of respiration occurring under
long-term exposure to NO. In our study, we demonstrated
that signi¢cant ROS generation is detected 1 h after NOC18
treatment, peaks at 6 h, and continues until 24 h (Fig. 3A).
This event was observed earlier than caspase activation and
the following apoptosis. Thus, it was suggested that NO from
NOC18 directly in£uences the mitochondrial respiratory chain
in its early stages. However, it is still unknown whether ROS
production leads to a death signal for apoptosis.
As another key molecule, cytochrome c released from the
mitochondria has been identi¢ed as an important factor that
can activate caspase-9. In fact, we have observed that the
levels of cytosolic cytochrome c are increased in response to
NOC18, and that the amounts of this protein in the mem-
brane fraction containing mitochondria show a corresponding
decrease in a time-dependent manner [29]. Unfortunately, the
precise mechanism for cytochrome c translocation by an ap-
optosis inducer is still unclear. Kim et al. [42] have reported
that cytochrome c release to the cytosol in response to treat-
ment with cytosine L-D-arabinofuranoside occurs with an ac-
companying decline in the mitochondrial transmembrane po-
tential. In contrast, the cytochrome c release induced by
staurosporine precedes the loss of mitochondrial membrane
potential [8]. In view of these results and other ¢ndings [43],
the relationship between mitochondrial membrane potential
and cytochrome c release remains controversial. On the other
hand, Bcl-2 and other related anti-apoptotic proteins have
been found to prevent cytochrome c release and to inhibit
caspase activation and apoptosis [44]. In contrast, pro-apo-
ptotic Bax and Bak stimulate cytochrome c release and induce
the loss of mitochondrial membrane potential [45^50]. It has
recently been reported that Bax and Bak, but not Bid and Bik,
elicit cytochrome c release accompanying the loss of mito-
chondrial membrane potential in the presence of Ca2 in iso-
lated mitochondria [51]. However, it is still unknown how
native Bcl-2 family proteins regulate the mitochondrial func-
tion. Hortelano et al. [52] have reported that NO triggers the
permeability transition in isolated mitochondria and that this
event can be detected 4 h after GSNO (an NO donor) chal-
lenge. The relationship between the mitochondrial permeabil-
ity transition and the following cytochrome c release, how-
ever, was not described. In the present study, we attempted
to determine whether or not NOC18 induces mitochondrial
membrane potential loss and cytochrome c release. As shown
in Fig. 3B, NOC18 evokes the loss of mitochondrial mem-
brane potential in a time-dependent manner with this loss of
mitochondrial membrane potential being detected slightly 12
h after NOC18 treatment (Fig. 3B). Under these conditions, a
signi¢cant release of cytochrome c has been observed 12 h
after NOC18 challenge [29]. In addition, in the present study,
there were no changes in the levels of Bcl-2 family proteins
such as Bcl-2, Bcl-XL, Bax, Bak, and Bid (data not shown).
These results showed that NOC18 elicits both cytochrome c
release to the cytosol from mitochondria and a loss of mito-
chondrial membrane potential with a similar time-course,
ROS production, however, precedes these events.
4.3. Relationship between mitochondrial membrane potential
loss and apoptosis via caspases
We next attempted to elucidate the relationship between the
loss of mitochondrial membrane potential and apoptosis
through cytochrome c release and caspase activation using
two compounds: CsA, a cyclophilin D inhibitor, and BA,
an adenine nucleotide translocator (ANT) inhibitor [53,54].
Both inhibitors reversed the loss of mitochondrial membrane
potential triggered by NOC18 (Fig. 4A,B). In that case, treat-
ment with CsA attenuated the release of cytochrome c to the
cytosol from mitochondria in response to NOC18 in a con-
centration-dependent manner (Fig. 4C). In addition, BA sup-
pressed NOC18-induced DNA fragmentation in SH-SY5Y
cells (Fig. 4D). These ¢ndings suggest that the inhibition of
mitochondrial membrane potential loss induced by prolonged
exposure to NO could attenuate the activation of a death
signal such as cytochrome c release and DNA fragmentation.
It is obvious that the mitochondrial PTPC consists of cyclo-
philin D, ANT, voltage-dependent anion channel (VDAC),
and several possible proteins. It is considered that the mito-
chondrial membrane potential is primarily regulated by PTPC
[55,56]. In view of our results, the compound that protects
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against mitochondrial membrane potential loss may be capa-
ble of attenuating neuronal apoptosis. Shimizu et al. [57] have
reported that the Bcl-2 family of proteins a¡ects VDAC and
regulates the mitochondrial membrane potential and release
of cytochrome c during apoptosis. However, we have no idea
how Bcl-2 family proteins are involved in the release of cyto-
chrome c in response to NO. Inhibitors of PTPC, however,
seem to be e¡ective against NO-induced neuronal apoptosis.
In summary, we here show that NO sequentially induces (1)
ROS production, (2) the loss of mitochondrial membrane po-
tential and cytochrome c release into the cytosol, (3) caspase
activation, and (4) DNA fragmentation. Treatment with non-
selective caspase inhibitor such as Z-Asp-CH2-DCB can block
NO-induced apoptosis [29]. Although the selective peptide in-
hibitors for caspases can attenuate the processing of each pro-
form of caspase, they cannot completely prevent the apoptosis
in response to NO (data not shown). In addition, our inves-
tigation showed that the overexpressed caspase-7 (C186G)
mutant does not function as a dominant-negative, possibly
due to the existence of intrinsic caspase, unlike the signal
transduction triggered by cytokine or growth factor (T. Ue-
hara, R. Moriya, and Y. Nomura, unpublished data). Since
the death signal is ampli¢ed as it moves downstream as acti-
vated caspase cleaves and activates its own and many other
caspases, the overexpression of mutant caspase seems to be
ine¡ective. Therefore, as reported here, the inhibition of the
death signal at the initiation stage or upstream is su⁄cient to
block the apoptosis induced by NO. In particular, PTPC se-
lectively attenuates NO-induced apoptosis (Fig. 4). Thus, the
inhibition of PTPC, which leads to the recovery of mitochon-
drial membrane potential loss, is likely to render neuronal
cells more resistant to the damaging e¡ects of NO and brain
ischemia.
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